Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

Imagine the impact on the shareprice IF the following two things happen prior to March 24th:

1. Navidea appears on the CHMP agenda for March and EU approval is granted. (This would also point very clearly to FDA approval and perhaps sooner than June 16th).

2. The sales for Q4 2013 put $500,000 or more into Navidea's coffers. This figure would be more than the Q2 and Q3 2013 amounts combined.

These two events happening before March 24th could potentially make the NAVB pps higher than Crede wants it to be. If both events do not happen, it is a virtual certainty in my mind that Crede will get all warrant shares at 2.00. It will be interesting to see if Navidea is saving a ton of good news for after March 24th to help their pals at Crede make even more guaranteed money, it sure as hell seems like Navidea could give a damn about the retail shareholder.